SEC Form 4 · accession 0001246360-17-002232
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew W Towse
Officer — SVP and Chief Financial Office
Period of report
Jun 20, 2017
Accepted (ET)
Jun 21, 2017 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2017 | M | 4,300 | $14.05 | A | 29,637 | D | |
| Common Stock | Jun 20, 2017 | S | 4,300 | $23.29 | D | 25,337 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.05 | Jun 20, 2017 | M | 4,300 | D | Jul 15, 2014 | Jul 14, 2023 | Common Stock | 4,300 | 16,930 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016.